Purple Biotech Ltd (PPBT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PPBT Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Purple Biotech Ltd's financial structure and capital allocation.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/PPBT/balance-sheets
https://api.csimarket.com/api/v1/companies/PPBT/fundamentals
https://api.csimarket.com/api/v1/companies/PPBT/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) 0 0 0
Assets
Cash And Cash Equivalents8.72
Cash & Short-term Investments8.00
Notes Receivable, Current0.01
Other Current Assets0.00
Total Current Assets9.87
Equipment/Property/Plant Net0.12
Intangible Assets7.36
Other Assets, Noncurrent1.37
Total Assets17.57
Liabilities
Other Liabilities, Current0.00
Total Current Liabilities7.75
Total Long-term Debt0.00
Total Liabilities7.91
Stockholders' Equity
Other Equity0.00
Common Stockholder's Equity9.66
Total Stockholder's Equity9.66
Liabilities & Stockholder's Equity17.57
4 historic quarters locked

Sign in to unlock the full Purple Biotech Ltd balance sheet history.

About Purple Biotech Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-031365

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI